Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects

Detalles Bibliográficos
Autores principales: Liu, Longlong, Patnana, Pradeep Kumar, Nimmagadda, Subbaiah Chary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166162/
https://www.ncbi.nlm.nih.gov/pubmed/35661690
http://dx.doi.org/10.1038/s41392-022-01040-9
_version_ 1784720544822722560
author Liu, Longlong
Patnana, Pradeep Kumar
Nimmagadda, Subbaiah Chary
author_facet Liu, Longlong
Patnana, Pradeep Kumar
Nimmagadda, Subbaiah Chary
author_sort Liu, Longlong
collection PubMed
description
format Online
Article
Text
id pubmed-9166162
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-91661622022-06-06 Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects Liu, Longlong Patnana, Pradeep Kumar Nimmagadda, Subbaiah Chary Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2022-06-04 /pmc/articles/PMC9166162/ /pubmed/35661690 http://dx.doi.org/10.1038/s41392-022-01040-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Highlight
Liu, Longlong
Patnana, Pradeep Kumar
Nimmagadda, Subbaiah Chary
Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects
title Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects
title_full Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects
title_fullStr Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects
title_full_unstemmed Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects
title_short Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects
title_sort low-dose metformin and pen2-dependent lysosomal ampk activation: benefits outnumber side effects
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166162/
https://www.ncbi.nlm.nih.gov/pubmed/35661690
http://dx.doi.org/10.1038/s41392-022-01040-9
work_keys_str_mv AT liulonglong lowdosemetforminandpen2dependentlysosomalampkactivationbenefitsoutnumbersideeffects
AT patnanapradeepkumar lowdosemetforminandpen2dependentlysosomalampkactivationbenefitsoutnumbersideeffects
AT nimmagaddasubbaiahchary lowdosemetforminandpen2dependentlysosomalampkactivationbenefitsoutnumbersideeffects

Ejemplares similares